Botulinum toxin in medicine and cosmetology – two hundred years’ history and new perspectives

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2018, Vol 72, Issue

Abstract

It has been nearly 200 years since the discovery of the botulinum toxin and the strain responsible for its synthesis Clostridium botulinum. Over this period, the knowledge about botulism and the use of botulinum toxin in medicine has been significantly expanded. Currently, eight serotypes of botulinum toxin (A-H) are known and they differ from each other by molecular weight, antigenic structure, immunogenicity, receptors, localization of coding genes and by the duration of the therapeutic effect. American physician Allan B. Scott was the first to demonstrate the use of botulinum toxin for medical purposes. Nowadays, botulinum toxin type A is widely used in medicine. Botulinum toxin injections are not only one of the most popular non-surgical aesthetic-cosmetic procedures, but are also widely used in neurology, ophthalmology and dermatology. The therapeutic potential of botulinum toxin has not been exhausted yet. Currently, many clinical trials are underway to extend the therapeutic indications of botulinum toxin and to improve its safety. Due to the huge development in medicine, botulinum toxin is today not only associated with aesthetic procedures and improvement in appearance, but also with raising the quality of life for people suffering from diseases with excessive muscle contraction and with other neuromuscular disorders.<br/><br/>

Authors and Affiliations

Małgorzata Zbrojkiewicz, Agata Lebiedowska, Barbara Błońska-Fajfrowska Barbara Błońska-Fajfrowska

Keywords

Related Articles

Rola surwiwiny w diagnostyce i terapii nowotworów ginekologicznych

Surwiwina należy do rodziny inhibitorów apoptozy, oprócz hamowania programowanej śmierci komórek, pełni również ważną rolę w regulacji proliferacji, naprawie DNA oraz autofagii. Obecność surwiwiny wykryto w większości lu...

Preliminary study on application of urine amino acids profiling for monitoring of renal tubular injury using GLC-MS

The early diagnosis of the nephrotoxic effect of xenobiotics and drugs is still an unsolved problem. Recent studies suggest a correlation between the nephrotoxic activity of xenobiotics and increased concentration of ami...

DNA microarray-based gene expression profiling in diagnosis, assessing prognosis and predicting response to therapy in colorectal cancer

Colorectal cancer is the most common cancer of the gastrointestinal tract. It is considered as a biological model of a certain type of cancerogenesis process in which progression from an early to late stage adenoma and...

Download PDF file
  • EP ID EP345607
  • DOI 10.5604/01.3001.0011.7617
  • Views 152
  • Downloads 0

How To Cite

Małgorzata Zbrojkiewicz, Agata Lebiedowska, Barbara Błońska-Fajfrowska Barbara Błońska-Fajfrowska (2018). Botulinum toxin in medicine and cosmetology – two hundred years’ history and new perspectives. Advances in Hygiene and Experimental Medicine, 72(), 278-289. https://europub.co.uk/articles/-A-345607